11-hydroxy-delta(9)-tetrahydrocannabinol has been researched along with piperidines in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonnet, D; Darwin, WD; Goodwin, RS; Gorelick, DA; Huestis, MA; Kelly, DL; Liu, F; McMahon, RP; Ortemann-Renon, C; Schwilke, E; Schwope, DM | 1 |
1 trial(s) available for 11-hydroxy-delta(9)-tetrahydrocannabinol and piperidines
Article | Year |
---|---|
Antagonist-elicited cannabis withdrawal in humans.
Topics: Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Humans; Male; Marijuana Abuse; Mass Spectrometry; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance Withdrawal Syndrome; Young Adult | 2011 |